KYRAS THERAPEUTICS
Kyras Therapeutics is a biotech company. According to data from the National Cancer Institute, more than 30 percent of all human cancers are driven by mutations in RAS genes, including 95% of pancreatic, 45% of colorectal, and 35% of lung cancers, among many others.
KYRAS THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.kyrasrx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Font API Content Delivery Network Domain Not Resolving
Current Employees Featured
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series A - Kyras Therapeutics
